FDA Device Recalls

Recalls /

#209082

Product

Philips Azurion Interventional Fluoroscopic X-ray System with Software Version Number: R1.0, R1.1, R1.2- Intended for Image guidance in diagnostic, interventional, and minimally invasive surgery procedures for the following clinical application areas: vascular, non-vascular, cardiovascular, and neuro procedure. Model Numbers: 722063, 722064, 722067, 722068, 722078 and 722079

FDA product code
OWBInterventional Fluoroscopic X-Ray System
Device class
Class 2
Medical specialty
Radiology
510(k) numbers
K200917
Affected lot / code info
Model /UDI-DI: (1) 722063 (01)00884838085275(21); (2) 722064 (01)00884838085282(21); (3) 722067 (01)00884838085350(21); (4) 722068 (01)00884838085367(21); (5) 722078 (01)00884838085251(21); (6) 722079 (01)00884838085268(21). Software Version Number: R1.0, R1.1, R1.2

Why it was recalled

Potential Loss of Imaging (X-ray) Functionality and/or Longer Time to Perform Cold Restart

Root cause (FDA determination)

Device Design

Action the firm took

Philips issued URGENT Medical Device Correction Letter to US consignees on July 15th, 2024, via certified mail. Letter states reason for recall, health risk and action to take: Circulate this Urgent Medical Device Correction to all users of the system so that they are aware of the issue. " Keep this Urgent Medical Device Correction with the documentation of the system until Philips corrects your system. Ensure that the letter is in a place likely to be seen/viewed. " Should you experience a loss of imaging (X-ray) functionality or a prolonged system restart time, call your local Philips representative to report the event. " Complete and return the attached response form (page 4) to Philips promptly and no later than 30 days from receipt. This confirms that the users of the system have reviewed and understand this Urgent Medical Device Correction and required actions to be taken. Philips is working on a software release (R2.2.10) that will correct these two issues (ref. FCOs: FCO72200548, FCO72200580, FCO72200582, FCO72200583, FCO72200584, FCO72200592). For those systems that have an Interventional Workspot (IW) and/or EchoNavigator, Philips will upgrade the software version of the IW and/or EchoNavigator to maintain compatibility with the updated Philips Azurion system software (R2.2.10). Your local Philips representative will contact you to schedule a visit to install the software update once available. Philips expects this software to be released by Q1 2025. If you need additional information or support concerning these issues, contact your local Philips representative at 1-800- 722-9377 (Philips Customer Care Solutions Center).

Recalling firm

Firm
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. Veenpluis 4-6 Best Netherlands

Distribution

Distribution pattern
Worldwide distribution - US Nationwide and the countries of Afghanistan, Albania, Algeria, Argentina, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Bosnia and Herzegovina, Brazil, Brunei Darussalam, Bulgaria, Cambodia, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Ethiopia, Finland, France, Germany, Ghana, Greece, Hong Kong, Hungary, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Korea, Republic of Kosovo, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Libya, Lithuania, Malaysia, Maldives, Mexico, Moldova, Mongolia, Morocco, Myanmar, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan Palestine, State of Peru, Philippines, Poland, Portugal, R¿union Romania, Russian Federation, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Thailand, Tunisia, Turkey, Ukraine, United Arab Emirates, United Kingdom, Uruguay, Uzbekistan, Viet Nam.

Timeline

Recall initiated
2024-07-15
Posted by FDA
2024-08-08
Status

Source: openFDA Device Recall endpoint. Recall record ID #209082. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.